Carmel Conlon

1.6k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Carmel Conlon is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Carmel Conlon has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Carmel Conlon's work include Heart Failure Treatment and Management (12 papers), Cardiovascular Function and Risk Factors (9 papers) and Cardiac pacing and defibrillation studies (3 papers). Carmel Conlon is often cited by papers focused on Heart Failure Treatment and Management (12 papers), Cardiovascular Function and Risk Factors (9 papers) and Cardiac pacing and defibrillation studies (3 papers). Carmel Conlon collaborates with scholars based in Ireland, Australia and Austria. Carmel Conlon's co-authors include Kenneth McDonald, Mark Ledwidge, Christina O’Loughlin, Anil Patle, John A. Baugh, Ramón Martos, Seamas C. Donnelly, Rory O’Hanlon, Niamh Murphy and Ian Dawkins and has published in prestigious journals such as JAMA, Circulation and The American Journal of Cardiology.

In The Last Decade

Carmel Conlon

17 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure

2013 384 citations Mark Ledwidge, J. Gallagher et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmel Conlon Ireland	10	990	134	128	122	92	19	1.1k
Germán Cediel Spain	18	700 0.7×	216 1.6×	80 0.6×	154 1.3×	57 0.6×	86	993
Thomas Sehestedt Denmark	15	744 0.8×	161 1.2×	121 0.9×	207 1.7×	104 1.1×	26	1.1k
Ioannis Karalis Netherlands	16	416 0.4×	163 1.2×	84 0.7×	100 0.8×	54 0.6×	42	699
Victor Voon Ireland	8	684 0.7×	84 0.6×	75 0.6×	49 0.4×	78 0.8×	17	824
Ankit Rathod United States	15	781 0.8×	123 0.9×	71 0.6×	135 1.1×	37 0.4×	41	1.1k
Fang‐Yang Huang China	15	384 0.4×	140 1.0×	83 0.6×	119 1.0×	43 0.5×	61	644
Mauro Feola Italy	19	848 0.9×	247 1.8×	159 1.2×	263 2.2×	42 0.5×	55	997
Sandeep Gautam United States	15	437 0.4×	185 1.4×	161 1.3×	101 0.8×	49 0.5×	56	820
Carlos Garcés Spain	7	581 0.6×	110 0.8×	39 0.3×	58 0.5×	118 1.3×	11	903
Burak Açar Türkiye	13	318 0.3×	133 1.0×	101 0.8×	57 0.5×	54 0.6×	99	641

Countries citing papers authored by Carmel Conlon

Since Specialization

Citations

This map shows the geographic impact of Carmel Conlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmel Conlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmel Conlon more than expected).

Fields of papers citing papers by Carmel Conlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmel Conlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmel Conlon. The network helps show where Carmel Conlon may publish in the future.

Co-authorship network of co-authors of Carmel Conlon

This figure shows the co-authorship network connecting the top 25 collaborators of Carmel Conlon. A scholar is included among the top collaborators of Carmel Conlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmel Conlon. Carmel Conlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Savage, Eileen, Breda Flood, Carmel Conlon, et al.. (2022). Developing a standardized national undergraduate curriculum for future healthcare professionals on self-management support for chronic conditions. Journal of Interprofessional Care. 37(1). 156–159. 2 indexed citations

Ledwidge, Mark, J. Gallagher, Carmel Conlon, et al.. (2013). Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure. JAMA. 310(1). 66–66. 384 indexed citations breakdown →

Collier, Patrick, Chris Watson, Ian Dawkins, et al.. (2012). Progression of Left Atrial Volume Index in a Population at Risk for Heart Failure: A Substudy of the STOP-HF (St Vincent's Screening to Prevent Heart Failure) Trial. European Journal of Heart Failure. 14(9). 957–964. 9 indexed citations

Conlon, Carmel, Ian Dawkins, Christina O’Loughlin, et al.. (2011). B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent’s Screening TO Prevent Heart Failure) study. Clinical Chemistry and Laboratory Medicine (CCLM). 49(4). 719–728. 6 indexed citations

Conlon, Carmel, et al.. (2011). P2-50 GGT levels are a coherent indicator of cardiovascular risk in primary care in both men and women: results from the stop HF study. Journal of Epidemiology & Community Health. 65(Suppl 1). A233–A233.

Martos, Ramón, John A. Baugh, Mark Ledwidge, et al.. (2009). Diagnosis of Heart Failure with Preserved Ejection Fraction: Improved Accuracy with the Use of Markers of Collagen Turnover. European Journal of Heart Failure. 11(2). 191–197. 96 indexed citations

O’Loughlin, Christina, Niamh Murphy, Mary Ryder, et al.. (2009). Causes and Consequences of Nonpersistence With Heart Failure Medication. The American Journal of Cardiology. 103(6). 834–838. 19 indexed citations

Phelan, Dermot, Mary Ryder, Niamh Murphy, et al.. (2009). Can we reduce preventable heart failure readmissions in patients enrolled in a Disease Management Programme?. Irish Journal of Medical Science (1971 -). 178(2). 167–171. 22 indexed citations

O’Loughlin, Christina, et al.. (2008). Need and Evolution of Need for Device Therapy in a Community Heart Failure Population. European Journal of Heart Failure. 10(6). 601–607. 3 indexed citations

10.

Mak, George, Niamh Murphy, Alison Walsh, et al.. (2008). Multiple Neurohumoral Modulating Agents in Systolic Dysfunction Heart Failure: Are We Lowering Blood Pressure Too Much?. Journal of Cardiac Failure. 14(7). 555–560. 12 indexed citations

11.

O’Loughlin, Christina, Niamh Murphy, Carmel Conlon, et al.. (2008). Quality of life predicts outcome in a heart failure disease management program. International Journal of Cardiology. 139(1). 60–67. 37 indexed citations

12.

Travers, Bronagh, Christina O’Loughlin, Niamh Murphy, et al.. (2007). Fluid Restriction in the Management of Decompensated Heart Failure: No Impact on Time to Clinical Stability. Journal of Cardiac Failure. 13(2). 128–132. 64 indexed citations

13.

O’Hanlon, Rory, Paula O’Shea, Mark Ledwidge, et al.. (2007). The Biologic Variability of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Stable Heart Failure Patients. Journal of Cardiac Failure. 13(1). 50–55. 108 indexed citations

14.

Sulaiman, Helmi, et al.. (2007). 9 A review of the actual need and evolution of need for device therapy in a community heart failure population. European Journal of Heart Failure Supplements. 6(1). 1–2. 1 indexed citations

15.

Conlon, Carmel, Anil Patle, Anne Marie Whelan, et al.. (2007). 332 Elevated B-type natriuretic peptide is associated with the presence of diastolic abnormalities in an asymptomatic, at-risk community population: The Screening TO Prevent Heart Failure (STOP HF) Study. European Journal of Heart Failure Supplements. 6(1). 75–75. 1 indexed citations

16.

Martos, Ramón, John A. Baugh, Mark Ledwidge, et al.. (2007). Diastolic Heart Failure. Circulation. 115(7). 888–895. 364 indexed citations

17.

Conlon, Carmel, et al.. (2007). 534 Discontinuation of heart failure medical therapy in a disease management programme predicts poorer outcome and increased costs. European Journal of Heart Failure Supplements. 6(1). 121–122. 1 indexed citations

18.

Graham, Fraser J, Mark Ledwidge, Carmel Conlon, et al.. (2006). Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: a marker of diastolic dysfunction and clinical risk. Irish Journal of Medical Science (1971 -). 175(4). 5–13. 6 indexed citations

19.

Conlon, Carmel, et al.. (2006). Community Direct Access Service for Early Detection and Treatment of Clinical Deterioration. Disease Management & Health Outcomes. 14(3). 185–190. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact